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Introduction
The axial and appendicular skeletons form through a process of endochondral ossification. During this process, mesenchymal progenitor cells within the cartilage anlage differentiate to chondrocytes. The chondrocytes then mature through resting, proliferating, and hypertrophic stages, and are finally replaced by invading osteoblasts and blood vessels (Kronenberg, 2003) . Meanwhile, skeletal progenitor cells within the perichondrium are progressively committed to an osteoblast lineage (Karsenty and Wagner, 2002; Long and Ornitz, 2013) . The perichondrium is the major reservoir of osteoblast precursors in developing long bones (Maes et al., 2010) , and osteoblast differentiation in the perichondrium is tightly regulated by the progressive action of osteoblast-specific transcription factors (Hartmann, 2009; Karsenty, 2008; Kobayashi and Kronenberg, 2005; Kronenberg, 2003; Long, 2012 ).
An array of cofactors, such as Maf, Taz, Satb2, Gli2, Dlx5, Bapx1 and Msx2, promote osteoblast differentiation by stimulating Runx2 expression or enhancing Runx2 activity (Long, 2012) . Runx2 is an early transcription factor that integrates multiple osteogenic signals to induce mesenchymal progenitor cells toward osteogenic commitment (Ducy et al., 1997; Komori et al., 1997; Otto et al., 1997) .
During endochondral bone formation, some of these osteogenic signals come from chondrocytes. For instance, Ihh secreted by prehypertrophic and hypertrophic chondrocytes promotes osteoblast differentiation by activating Runx2. After Runx2 stimulates osteogenic commitment, Osterix and ATF4 sequentially enforce the differentiation and maturation of these osteoblasts (Ducy et al., 1996; Nakashima et al., 2002; Yang et al., 2004) . Conversely, osteoblast differentiation is suppressed by repressors such as Twist1, Hand2, Zfp521, Schn3, Stat1, Tle, Hey, Hes and Hdac4, which perturb DNA binding or nuclear translocation by Runx2, decrease Runx2 protein expression, or degrade Runx2 protein (Javed et al., 2010; Long, 2012) . Loss of Runx2 activators or cofactors impairs bone formation or homeostasis (Komori et al., 1997) , and genetic inactivation of Runx2 repressors leads to enhanced osteoblast differentiation or ectopic ossification. For instance, Hand2 null mice displayed enhanced ossification in the branchial arch (Funato et al., 2009 ).
The Fox family of transcription factors, characterized by a highly conserved forkhead DNA-binding domains, are essential for regulating several developmental processes (Augello et al., 2011; Eijkelenboom and Burgering, 2013; Katoh et al., 2013; Kume, 2011; Raychaudhuri and Park, 2011) . For example, the Foxp1/2/3/4 subfamily regulates differentiation or proliferation of cardiomyocytes (Wang et al., 2004; Zhang et al., 2010) , B and T cells (Duhen et al., 2012; Feng et al., 2009; Hu et al., 2006; Wang et al., 2014) , ES cells (Gabut et al., 2011) and various malignant cell-types (Chen et al., 2011; Koon et al., 2007; Korac et al., 2009) . This subfamily regulates cell differentiation through transcriptional repressor activity. Foxp1/2/4 proteins generally show overlapping expression patterns in the lung, gut, and brain during development (Lu et al., 2002; Shu et al., 2007; Takahashi et al., 2008) , and in some cases, these proteins are known to act cooperatively (Li et al., 2012; Li et al., 2004) . However, the role of Foxp1/2/4 genes in bone development remains unclear. In this report, we employ genetic, histological and molecular approaches to investigate the role of Foxp genes during endochondral ossification. Our findings identify the Foxp1/2/4 complex as a novel Runx2 suppressor that regulates endochondral ossification.
Materials and methods

Mice
The Foxp1 fl/fl (Feng et al., 2009) , Foxp2 fl/fl (French et al., 2007) , transgenic mice Prx1-Cre (Logan et al., 2002) and Col2-Cre mice (Lu et al., 2013 ) have been described in previous studies. For transgenic mice generation, Foxp1 (NM_053202.2) cDNA, Foxp2 (BC058960) cDNA and Foxp4 (BC057110) cDNA were individually driven by Col2a1 promoter and enhancer as previously reported (Yang et al., 2003) .
The genotyping primers for the mice are provided in supplementary material Table S1 . The genetic backgrounds of all knockout mice were uniform mixtures of 129S1/SvIMJ and C57Bl/6J. All transgenic mice were ICR background. All animal procedures were performed in accordance with protocols set by Shanghai Jiao Tong University (SYXK 2011-0112) .
Generation of Foxp4 conditional knockout mice
Two Loxp sites were inserted into the Foxp4 gene at introns 9 and 14 (supplemental material Fig. S4A ). The targeted ES clones were identified by PCR using primers P1/P2 and P3/P4 that generate 5473 bp and 4648 bp products, respectively (supplementary material Fig. S4B ). The conditional allele of Foxp4 fl is genotyped by primers P5/P6 as a 290 bp fragment. Foxp4 was efficiently deleted by E13.5 limbs from Prx1-Cre; Foxp4 fl/fl mice (supplementary material Fig. S4D and E).
Mice of homozygous Foxp4 fl/fl showed no obvious abnormality throughout life, suggesting the Foxp4 fl allele functions normally.
Skeletal preparation, histological, IHC analyses and lacZ staining
Paraffin and frozen sections of skeletal samples from the transgenic and knockout mice at E15.5, E16.5 and E18.5 were obtained and processed as previously reported (Guo et al., 2004) . Sections were stained as previously described using H&E for general histology (Beyotime), von Kossa for analysis of mineralization, and safranin O for analysis of proteoglycans (Guo et al., 2004) . The primary antibodies for IHC were the following: anti-Osterix (1:50, Abcam, ab22552), anit-Runx2 (1:50, Santa Cruze, sc-10758), anit-Collagen Type (1:50, Millipore, AB765P), anti-Foxp1 Fluorescent microscopic images were taken using a Leica SP5 confocal microscope.
For LacZ staining, the samples were at first performed by whole mount X-gal staining as done previously (Day et al., 2005) , and then re-fixed and sectioned with 10 ȝm thick to observe the Cre enzyme activity.
In situ hybridization BrdU labeling and TUNEL assay
In situ hybridization for whole mount embryos or sections was performed using digoxin-labeled probes as previously described (Guo et al., 2009 cDNA were amplified by PCR and subcloned into the pGEM-T vector to generate RNA probes, respectively. All the oligos are provided in supplementary material Table   S1 . Other probes have been described previously: Sox9, Col2a1, Col10a1, Mmp13, Opn, Ihh, Pthrp, Osx, Col1a1 (Akiyama et al., 2004; Guo et al., 2004) . For bromodeoxyuridine (BrdU) labeling, mice received an intraperitoneal injection of BrdU (100ȝg/g of body mass; Sigma). Two hours later, mice were sacrificed and embedded in paraffin for sectioning. TUNEL staining was performed using DeadEnd™ Fluorometric TUNEL System kit (Promega) according to the manufacturer's instructions.
Luciferase reporter assay, cell culture and qRT-PCR
HEK-293T or Cos7 cells with a density of 0.5 x 10 5 were plated in 24-well tissue and cultured until 90% confluent. Cells were transfected according to manufacturer's instructions using using lipofectamine TM 2000 (Invitrogen). Expression plasmids for p6OSE2-luc, pOG2-luc, pOG2mOSE2-luc reporter constructs have been described previously (Ducy and Karsenty, 1995) . Cos7 cells were transfected with p6OSE2-luc Luciferase assays were performed 48 hours after transfection by using the Dual Luciferase Kit (Promega).
The full-length cDNA of Foxp4 (BC057110) or EGFP (used as control) were amplified by PCR and subcloned into the PMSCVpuro retroviral vector. Retrovirus was generated by transfection of PMSCVpuro-Foxp4 construct or PMSCVpuro-GFP construct into Platinum-E Retroviral packaging cells using FuGENE 6 (Roche).
ATDC5 cells were cultured in a medium of DMED/F-12 supplemented with 5% FBS (Invitrogen). To induce chondrogenic differentiation of ATDC5 cells, the cells upon reaching confluence were induced by differentiation medium by addition of insulin (10 ȝg/ml, Sigma), human transferrin (10 ȝg/ml, Sigma), and sodium selenite (10 ȝg/ml, Sigma). The ATDC5 cells overexpressing Foxp4 or GFP protein were obtained by retroviral infection and puromycin resistance selection. Similar overexpression was performed in MC3T3 cells. MC3T3 cells were cultured in ɲ-MEM medium (Invitrogen) including 10% FBS. For osteogenic introduction, the cells were cultured in the medium with addition of 10 mM ɴ-glycerolphosphate (Sigma), 50 ȝg/ml ascorbic acid (Sigma), and 10 nM dexamethasone (Sigma). Alcian blue staining for ATDC5 cells was performed as previously report (Atsumi et al., 1990 Table S1 .
Plasmids
The epitope-tagged derivatives of full-length Foxp1 (NM_053202.2), Foxp2 
Statistical analyses
Statistical analysis was performed by Student's t test using GraphPad Prism 5
software. Data are represented as means ± SEM, and significance was set at p 0.05.
For BrdU labeling, at least three individual samples analyzed and five to ten consecutive sections from each sample were taken into account. distal humerus, the range of Foxp1/2/4 expression in the perichondrium was similar to
Results
Foxp1
Runx2, but differed from that of the osteoblast marker Osx (arrows in Fig. 1Ca -e), implying that Foxp1/2/4 may be active in the same cell types as Runx2. Indeed, the Foxp1/2/4 proteins were mostly located in the nuclei of perichondrial cells, partially overlapping with the Runx2 distribution (arrows in Fig. S1B ). In addition to the expression of Foxp1/2/4 in perichondrium, Foxp2 and Foxp4 were detected at relatively lower levels in proliferating chondrocytes (Fig. 1Cb, c ). These results demonstrate that the murine Foxp1/2/4 genes are redundantly expressed in the perichondrium and proliferating chondrocytes of developing long bones.
Over-expression of Foxp1/2/4 in chondrocytes abrogates skeletal ossification
To investigate the roles of Foxp1/2/4 in skeletogenesis, we generated transgenic mice that overexpress Foxp1, Foxp2, and Foxp4 transgenic mice in chondrocytes under the control of Col2a1 promoter and enhancer. We obtained two or three independent founders for each transgenes. The severity of the ossification defect varied between founders with the same transgene, possibly due to the variances in copy number or ectopic expression levels of the transgene. The founders with the most severe defects were selected for further study. The over-expression of Foxp1/2/4 in the chondrocytes of skeletons from each transgenic mouse was validated by IHC with anti-Foxp1, anti-Foxp2 or anti-Foxp4 polyclonal antibodies (Fig. S2) . The
Col2-Foxp1, Col2-Foxp2 and Col2-Foxp4 transgenic mice all showed perinatal lethality and smaller size compared to wild-type controls ( Fig. 2A) . The transgenes produced remarkable defects in endochondral ossification, as indicated by decreased Alizarin red staining in skeletal preparations of forelimbs and hindlimbs of transgenic mice compared to controls . In contrast to the development of long bones, Alizarin red staining in the skulls was impaired in a relatively less extent in the transgenic embryos ( Fig. 2A d-d") . Therefore, overexpression of Foxp1/2/4 in chondrocytes inhibits endochondral ossification.
The expression of Col2a1 was relatively decreased in the chondrocytes from Foxp transgenic skeletons ( Fig. 2Bb-b" ). In addition, marked decreases of Col10a1
(hypertrophic chondrocyte marker, Bc-c", Bg, Bg', Bi-i'), Opn (osteoblast marker, Fig. 2Be-e", k-k') and Col1a1 (osteoblast marker, Figs. 2Bf-f", l-l'), safranin O ( To analyze skeletal deformities in Foxp mutant mice at E18.5 and P10, overall skeletal preparations were analyzed with Alcian blue and Alizarin red staining. At E18.5, the overall body size and the appendicular skeleton were shortened in the single and compound Foxp mutants compared to the wild-type controls (Figs. 3A) . By P10, the severity of attenuated skeletal growth increased as the genetic dosage of Foxp1/2 decreased (Fig. 3C ). Defective skeletal development was not limited to the appendicular skeletons, as bone malformations were also detected in the skull. In the (Figs. 3Ba-f) . Together, these observations suggest that Foxp genes cooperatively regulate skeletal development in a dose-dependent manner.
Foxp deficiency in perichondrium and chondrocytes perturbs skeletal development
To identify the molecular changes associated with defective skeletal development in the Foxp mutants, we performed histological and IHC analyses in sections from E18.5 tibia of mutant and control mice (Fig. 4) . In the control tibia O, 5Ak-l) and Opn (Fig. 4S, T ). These findings demonstrate advanced osteoblast differentiation, maturation and mineralization during endochondral ossification in
Foxp-deficient mice. Therefore, we hypothesized that that the Foxp genes may regulate osteogenic commitment.
Foxp deficiency in skeletal progenitor cells leads to precocious osteogenic commitment
To explore the effect of Foxp deficiency on osteogenic commitment of skeletal progenitor cells, we used Prx1-Cre to eliminate Foxp in the mesenchymal progenitor cells (Logan et al., 2002 Fig. S7A ), indicative of decreased chondrocyte hypertrophy.
In contrast, the Col2-Cre; Foxp1/2 fl/fl mutant showed an increase in proliferating or prehypertrophic chondrocytes compared to the control, assessed by expression of Ihh and Pthc1 (arrows in Fig. S7B ). Therefore, Foxp deficiency may delay chondrocyte hypertrophy and maturation during endochondral ossification.
Next, to assess whether decreased proliferation or increased apoptosis might contribute to the reduction in hypertrophic chondrocytes, we performed the BrdU assay described above and TUNEL analysis in the proximal tibia of E18. 
Foxp1/2/4 proteins inhibit the transacriptional activity of Runx2
The defects in endochondral ossification observed in Foxp deficient mice were opposite to previously described in Runx2 -/-mice (Komori et al., 1997; Takarada et al., 2013) . Given the overlapping expression patterns of Foxp and Runx2, we suspected that Foxp1/2/4 may influence osteogenic differentiation and chondrocyte hypertrophy by regulating Runx2. To address this possibility, we first examined the impact of Foxp proteins on Runx2 transactivation via reporter assays employing luciferase constructs (pOG2-Luc or p6OSE2-Luc) driven by consensus Runx2 binding sites in their promoters (Ducy and Karsenty, 1995 (Fig. 7D) , suggesting that these proteins may directly bind the Runt domain of Runx2. Foxp proteins contain forkhead, leucine-zipper and zinc-finger domains, which are responsible for DNA-binding and homotypic or heterotypic proteins interactions, respectively (Wang et al., 2003) . To determine which domain(s) are involved in Runx2 suppression, we created construct for expressing the Foxp1 N-terminal domain, middle domain (M, containing the leucine zipper and zinc finger domain), or C-terminal domain (containing the forkhead domain) independently or the N-terminal and middle domains together. In the luciferase assay with full-length Runx2, each domain of Foxp1 suppressed Runx2 transactivation (Fig. 7E) , although no single domain suppressed Runx2 activity as effectively as the full-length protein.
Collectively, these findings suggest that Foxp complexes may downregulate Runx2 activity during endochondral ossification by interacting with the Runt domain.
The Foxp1/2/4 complex interacts with Runx2
To directly test whether Foxp1/2/4 proteins can interact with Runx2, we To identify the domains involved in the interaction between Foxp1/2 and Runx2, truncated forms of Runx2 were cotransfected into Cos7 cells with Flag-tagged Runx2, and interactions were assessed by co-immunoprecipitation and His-tagged Foxp1/2/4 vectors (Fig. 8G ). All forms of Runx2 that included the Runt domain interacted with Foxp2, while forms of Runx2 that lacked the Runt domain did not interact with Foxp2 (Figs. S9) . Next, we used co-immunoprecipitation to test whether the Foxp1 C-terminal domain, which contains the forkhead domain, was sufficient for interactions with full-length Runx2. Indeed, the Foxp1 C-terminal domain was co-immunoprecipitated with Runx2 (Fig. 8F) . Taken together, these results imply that We propose that Foxp1/2/4 proteins coordinate osteogenesis and chondrogenesis during long bone development by regulating Runx2 (Fig. 8K ). This is a central factor in regulating bone development, as several repressors or corepressors, including Twist1/2, Zfp521 and Hdac4, have been reported to modulate osteoblast differentiation and chondrocyte hypertrophy through their differential interaction with Runx2 protein Correa et al., 2010; Hesse et al., 2010; Shimizu et al., 2010; Vega et al., 2004) . Runx2 Osx were slightly elevated in perichondrium adjacent to resting or proliferating chondrocytes. Given that elevated Runx2 expression in the perichondrium has been shown to inhibit chondrocyte proliferation and hypertrophy (Hinoi et al., 2006) , the gross defects in bone development in the Foxp mutants may result from combined regulation of Runx2 activity in the perichondrium and proliferating chondrocytes.
However, it is important to note that the Foxp proteins may coordinate osteogenesis and chondrogenesis via multiple pathways, including pathways that are independent of Runx2. For example, Foxo proteins have been reported to regulate osteoblast proliferation and differentiation through interactions with Runx2, CREB and ATF4 (Almeida, 2011; Kode et al., 2012) . and the His-tagged Foxp1-C fragment, which included the forkhead domain (FH).
Co-immunoprecipitation was performed as indicated.
(G) Proposed mechanism by which the Foxp complex regulates osteogenesis and chondrocyte hypertrophy of the growth plate: Foxp1/2/4 complex regulates osteoblast differentiation and chondrocyte hypertrophy partially through inhibiting Runx2 activity.
Highlight:
Foxp1/2/4 and Runx2 expression overlap in the perichondrium and proliferating chondrocytes.
Over-expression of Foxp1/2/4 genes abrogates osteoblast differentiation and chondrocyte hypertrophy.
Deficiency of Foxp1/2/4 genes leads to precocious ossification and defective chondrogenesis in the growth plates. 
